The Risks and Benefits of Corticosteroids in Advanced Cancer
- 1 September 1994
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 11 (3) , 163-178
- https://doi.org/10.2165/00002018-199411030-00003
Abstract
Corticosteroids are extensively prescribed in advanced cancer for various specific indications (e.g. spinal cord compression), for pain relief, as hormone therapy and to stimulate appetite and...Keywords
This publication has 72 references indexed in Scilit:
- Dexamethasone treatment reduces sensory neuropeptides and nerve sprouting reactions in injured teethPain, 1993
- Hypersensitivity to dexamethasone.BMJ, 1993
- Five-Drug Antiemetic Combination for Cisplatin ChemotherapyCancer Investigation, 1992
- Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter studyEuropean Journal of Cancer and Clinical Oncology, 1989
- Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimensBlood Reviews, 1989
- Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.BMJ, 1988
- EFFECTS OF DEXAMETHASONE IN BRAIN TUMOUR PATIENTSThe Lancet, 1987
- Osteoarthritis a new neurological method of pain controlMedical Hypotheses, 1984
- ASEPTIC NECROSIS OF BONE FOLLOWING RENAL TRANSPLANTATIONMedicine, 1978